External Advisory Board

Angelique Lee,
JD

VP, Chief Compliance and Ethics Officer at Jazz Pharmaceuticals

Steven Pfeiffer,
PhD, MBA

Senior Vice President of  Beren Therapeutics 

Vern Norviel,
JD, MS

Partner, Wilson Sonsini Goodrich & Rosati

Ellen L. Berg
PhD

Chief Scientific Officer, Alto Predict

View Bio

Bill Lundberg,
MD

President, CEO and Principal Financial Officer of Merus, NV

Melissa Seymour,
MBA

CQO, SVP Global Quality Bristol Myers Squibb, Inc.

Nicole C. Kleinstreuer,
PhD

Nancy Lurker,
MBA

President and CEO, EyePoint Pharmaceuticals

Jeff Sherman,
MD, FACP

Chief Medical Officer and Executive Vice President at Horizon Therapeutics

Harold E. "Barry" Selick,
PhD

Former Vice-Chancellor of Business Development, Innovation, and Partnerships at the University of California, San Francisco

Applications portal is now closed  

for the 2024/2025 academic year

We will be accepting applications for 2025/26

in the Fall of 2024.

APPLY HERE


Questions? Contact us!
mtramstudies@stanford.edu

Important Dates

September 2024 to January 2024:

  • Applications accepted for 2025/26

 

December, 2024 (date tba):

  • M-TRAM info session webinar for prospective students 

 

January 15, 2025:

  • Applications are due for 2025/26

 

April, 2025:

  • Admission Decisions

 

Sept. 2025: (date tba)

  • M-TRAM research symposium and New Students Orientation (in person) - stay tuned for registration info

 

Sept. 22, 2025:

  • First day of classes at Stanford (M-TRAM program starts)

 

Interested in Becoming an M-TRAM Industry Partner?

We welcome inquiries from biotechnology, pharmaceutical and other health care organizations interested in learning about opportunities to partner with M-TRAM: 

mtramstudies@stanford.edu